Impact Factor
2.60
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.17
164 total citations
h5-index
15
h5 depth signal
Cited share
58.5%
86 of 147
Total citations
164
Citation footprint
Metric signal
1.05
External metric anchor
Self-citation
3.0%
5 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
208
China
129
Turkey
87
Italy
78
Spain
64
Citing Fields of Research
Hematology
923
Cardiology
123
Clinical Laboratory Science
104
Genetics & Genomics
56
Vascular Disorders
42
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
5,160
Articles tracked across the journal lifetime
Indexed publication set
147
86 cited publications
Last 12 months
69
5.8 publications/month
Open access share
10.1%
7 OA publications in the last year
Leading citing country
United States
208 citing publications
Leading citing field
Hematology
923 citing publications
Latest tracked publication
20 October 2026
10 recent records available
Coverage & Indexing History
v1n1,Mar./Apr. 1990-
v1n1,Mar./Apr. 1990-
Active Coverage
Research Focus & Classification
Indexed Subjects
Hematology
Broad Categories
Hematology
Vascular Diseases
MeSH Descriptors
Blood Coagulation
Fibrinolysis
Hemostasis
Thrombosis
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1097/mbc.0000000000001470
Open DOI
A review of the monitoring of argatroban by anti-IIa methods, ecarin assays, point-of-care testing methods and specialized drug quantification methods for patients with heparin-induced thrombocytopenia
Heparin-induced thrombocytopenia (HIT) is caused by anti-PF4/heparin IgG antibodies stimulating platelet activation, causing thrombocytopenia and thrombosis. Classical HIT occurs due to exposure to heparin, whereas autoimmune HIT occurs ...
02
DOI 10.1097/mbc.0000000000001468
Open DOI
Successful systemic fibrinolysis in pulmonary embolism with a thrombus-in-transit
Right heart thrombus-in-transit with acute pulmonary embolism (PE) is a rare but potentially lethal clinical finding. Optimal management remains controversial, particularly when major contraindications or risk factors coexist. We present...
03
DOI 10.1097/mbc.0000000000001463
Open DOI
Heavy menstrual bleeding with direct oral anticoagulants and vitamin K antagonists: a systematic review and meta-analysis
Heavy menstrual bleeding (HMB) is a clinically important but underrecognized complication of oral anticoagulation that can impair quality of life, cause of iron deficiency or anaemia, and lead to treatment interruption. We conducted a sy...
04
DOI 10.1097/mbc.0000000000001465
Open DOI
Autologous hematopoietic stem cell transplantation in a patient with relapsed diffuse large B-cell lymphoma and type 3 von Willebrand disease: a case report
Autologous hematopoietic stem cell transplantation (auto-HSCT) is standard therapy for eligible patients with relapsed diffuse large B-cell lymphoma (DLBCL). Type 3 von Willebrand disease (VWD) poses additional haemostatic challenges dur...
05
DOI 10.1097/mbc.0000000000001461
Open DOI
Investigating the relationship between age and gender of blood donors with oxidative stress, and mitochondrial DNA release in platelet concentrates during storage
The variations in donor characteristics, may affect the progression of platelet storage lesion (PSL). Additionally, oxidative conditions and mitochondrial function play a role in these alterations. This study aims to investigate the impa...
06
DOI 10.1097/mbc.0000000000001464
Open DOI
Clinical characteristics, risk factors, and outcomes of pediatric thrombosis: a prospective single-center study
The incidence of pediatric thrombosis is increasing due to multiple causes and risk factors, including genetic and acquired factors. This study aimed to evaluate clinical characteristics, risk factors, genetic mutations, and clinical out...
07
DOI 10.1097/mbc.0000000000001467
Open DOI
TMPRSS2-coagulation nexus: a novel molecular link revealed by pairwise correlation analysis following AstraZeneca (ChAdOx1 nCoV-19) vaccination in a Nigerian cohort
Objective: To investigate the pairwise molecular-haematological and coagulation correlations, specifically evaluating the relationship between TMPRSS2 gene expression and coagulation profiles, following AstraZeneca (ChAdOx1 nCoV-19) vacc...
08
DOI 10.1097/mbc.0000000000001466
Open DOI
Appropriateness of antiphospholipid antibody testing and its impact on diagnostic yield and clinical outcomes: a multicentre cohort study
Antiphospholipid syndrome (APS) is an uncommon but important cause of thrombosis and pregnancy morbidity. Despite guidelines, antiphospholipid antibody (aPL) testing is frequently performed outside specialist settings, potentially reduci...
09
DOI 10.1097/mbc.0000000000001448
Open DOI
BCR::ABL1 analysis is not indicated in the thrombophilia work-up of patients with splanchnic vein thrombosis
Was not provided for this article.
10
DOI 10.1097/mbc.0000000000001450
Open DOI
Validation of a chromogenic assay to detect factor VIII inhibitors in hemophilia patients on emicizumab
Was not provided for this article.
Bibliographical & Catalog Notes
Title from cover.
Also issued online.
Vol. 2, no. 4 (1991)19920824 Notice published Printed on acid-free paper that meets the full ANSI standard for Permanent Paper